{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:22:15Z","timestamp":1761765735948,"version":"build-2065373602"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.ajp.2013.11.017","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T00:01:59Z","timestamp":1386633719000},"page":"12-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Association between antipsychotic-induced metabolic side-effects and clinical improvement: A review on the Evidence for \u201cmetabolic threshold\u201d"],"prefix":"10.1016","volume":"8","author":[{"given":"Eesha","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naren P.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesan","family":"Venkatasubramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2013.11.017_bib0005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1192\/bjp.184.5.383","article-title":"Foetal origins of schizophrenia: testable hypotheses of genetic and environmental influences","volume":"184","author":"Abel","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0010","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0015","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2165\/00023210-200822070-00002","article-title":"Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal","volume":"22","author":"Alvarez-Jimenez","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajp.2013.11.017_bib0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-244X-5-3","article-title":"Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia","volume":"5","author":"Ascher-Svanum","year":"2005","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0025","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1176\/ajp.2006.163.7.1276","article-title":"Association of initial antipsychotic response to clozapine and long-term weight gain","volume":"163","author":"Bai","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0030","doi-asserted-by":"crossref","first-page":"18276","DOI":"10.1073\/pnas.0706481104","article-title":"Leptin replacement alters brain response to food cues in genetically leptin-deficient adults","volume":"104","author":"Baicy","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ajp.2013.11.017_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0149-7634(95)00033-B","article-title":"Food reward: brain substrates of wanting and liking","volume":"20","author":"Berridge","year":"1996","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ajp.2013.11.017_bib0040","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1192\/bjp.169.6.682","article-title":"Cholesterol and mental disorder","volume":"169","author":"Boston","year":"1996","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0045","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0006-3223(96)00102-3","article-title":"Serum cholesterol and treatment-resistance in schizophrenia","volume":"40","author":"Boston","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0050","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/S0033291798008186","article-title":"The unhealthy lifestyle of people with schizophrenia","volume":"29","author":"Brown","year":"1999","journal-title":"Psychol. Med."},{"key":"10.1016\/j.ajp.2013.11.017_bib0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000054536","article-title":"The long form of the leptin receptor (OB-Rb) is widely expressed in the human brain","volume":"71","author":"Burguera","year":"2000","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ajp.2013.11.017_bib0060","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1176\/ajp.153.6.817","article-title":"Differential effect of clozapine on weight: a controlled study","volume":"153","author":"Bustillo","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1191\/0960327102ht217oa","article-title":"Defining hormesis","volume":"21","author":"Calabrese","year":"2002","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ajp.2013.11.017_bib0070","first-page":"325","article-title":"Genetic variants of the human obesity (OB) gene: association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRD2) gene","volume":"1","author":"Comings","year":"1996","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0075","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00004714-200206000-00003","article-title":"Antipsychotic-induced weight gain and therapeutic response: a differential association","volume":"22","author":"Czobor","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2013.11.017_bib0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.schres.2007.01.015","article-title":"A clinical study of the association of antipsychotics with hyperlipidemia","volume":"92","author":"de Leon","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2013.11.017_bib0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/j.2051-5545.2009.tb00199.x","article-title":"Metabolic syndrome in people with schizophrenia: a review","volume":"8","author":"DEHert","year":"2009","journal-title":"World Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0090","first-page":"453","article-title":"The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study","volume":"24","author":"Dursun","year":"1999","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.ajp.2013.11.017_bib0095","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2013.11.017_bib0100","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1176\/ps.2009.60.4.538","article-title":"Psychiatric illness and obesity: recognizing the \u201cobesogenic\u201d nature of an inpatient psychiatric setting","volume":"60","author":"Faulkner","year":"2009","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.ajp.2013.11.017_bib0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0006-8993(02)04087-8","article-title":"Expression of receptors for insulin and leptin in the ventral tegmental area\/substantia nigra (VTA\/SN) of the rat","volume":"964","author":"Figlewicz","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.ajp.2013.11.017_bib0110","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/mp.2008.40","article-title":"Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway","volume":"13","author":"Girgis","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00004714-199906000-00014","article-title":"Olanzapine: weight gain and therapeutic efficacy","volume":"19","author":"Gupta","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2013.11.017_bib0120","first-page":"148","article-title":"Paradoxical hypertension associated with clozapine","volume":"151","author":"Gupta","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0125","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/schbul\/6.4.619","article-title":"Followup treatment and aftercare of discharged schizophrenic patients","volume":"6","author":"Haase","year":"1980","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2013.11.017_bib0130","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.schres.2011.01.022","article-title":"The association between weight change and symptom reduction in the CATIE schizophrenia trial","volume":"128","author":"Hermes","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2013.11.017_bib0135","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/sj.ijo.0801563","article-title":"Relatively low serum leptin levels in adults born with intra-uterine growth retardation","volume":"25","author":"Jaquet","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ajp.2013.11.017_bib0140","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.mp.4002000","article-title":"Metabolomic mapping of atypical antipsychotic effects in schizophrenia","volume":"12","author":"Kaddurah-Daouk","year":"2007","journal-title":"Mol. Psychiatry"},{"issue":"9618","key":"10.1016\/j.ajp.2013.11.017_bib0145","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2013.11.017_bib0150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.jcp.0000161501.65890.22","article-title":"Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders","volume":"25","author":"Kinon","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2013.11.017_bib0155","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/schbul\/sbm140","article-title":"Is schizophrenia a syndrome of accelerated aging?","volume":"34","author":"Kirkpatrick","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2013.11.017_bib0160","first-page":"102","article-title":"Weight changes during treatment with phenothiazine derivatives","volume":"2","author":"Klett","year":"1960","journal-title":"J. Neuropsychiatr."},{"key":"10.1016\/j.ajp.2013.11.017_bib0165","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1176\/ajp.149.5.689","article-title":"Weight gain among schizophrenic patients treated with clozapine","volume":"149","author":"Lamberti","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0170","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4088\/JCP.v64n0314","article-title":"Effects of patient demographics, risperidone dosage, and clinical outcome on body weight in acutely exacerbated schizophrenia","volume":"64","author":"Lane","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0175","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1176\/ajp.149.1.68","article-title":"Clozapine-induced weight gain: prevalence and clinical relevance","volume":"149","author":"Leadbetter","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0180","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2337\/diacare.26.5.1597","article-title":"Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes","volume":"26","author":"Lean","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajp.2013.11.017_bib0185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/mp.2011.109","article-title":"Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications","volume":"17","author":"Lett","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0190","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2013.11.017_bib0195","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0193-953X(02)00033-3","article-title":"Is schizophrenia a metabolic brain disorder? Membrane phospholipid dysregulation and its therapeutic implications","volume":"26","author":"Mahadik","year":"2003","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.ajp.2013.11.017_bib0200","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1210\/jc.2004-1979","article-title":"Effect of leptin replacement on brain structure in genetically leptin-deficient adults","volume":"90","author":"Matochik","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ajp.2013.11.017_bib0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0920-9964(01)00326-7","article-title":"Clozapine-induced weight gain predicts improvement in psychopathology","volume":"59","author":"Meltzer","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2013.11.017_bib0210","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/157015909790031184","article-title":"Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part II","volume":"7","author":"Miller","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ajp.2013.11.017_bib0215","first-page":"617","article-title":"Adverse effects of antipsychotic medications","volume":"81","author":"Muench","year":"2010","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.ajp.2013.11.017_bib0220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF01561635","article-title":"Changes in weight in patients receiving a tranquilizing drug","volume":"32","author":"Planansky","year":"1958","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.ajp.2013.11.017_bib0225","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1139\/jpn.0733","article-title":"Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment","volume":"32","author":"Procyshyn","year":"2007","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.ajp.2013.11.017_bib0230","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1176\/appi.ajp.160.4.677","article-title":"Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain","volume":"160","author":"Reynolds","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0235","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia","volume":"160","author":"Ryan","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0240","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.psyneuen.2003.08.011","article-title":"Evidence of basal pituitary-adrenal overactivity in first episode, drug naive patients with schizophrenia","volume":"29","author":"Ryan","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ajp.2013.11.017_bib0245","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0899-9007(97)91277-6","article-title":"Hypothalamic neuronal histamine: implications of its homeostatic control of energy metabolism","volume":"13","author":"Sakata","year":"1997","journal-title":"Nutrition"},{"key":"10.1016\/j.ajp.2013.11.017_bib0250","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/schbul\/sbm141","article-title":"Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review","volume":"34","author":"Sentissi","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2013.11.017_bib0255","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.psychres.2010.07.012","article-title":"Relation between weight gain and clinical improvement: is there a metabolic threshold for second generation antipsychotics?","volume":"186","author":"Sharma","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ajp.2013.11.017_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00163-3","article-title":"A review of MRI findings in schizophrenia","volume":"49","author":"Shenton","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2013.11.017_bib0265","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0033-3182(70)71577-6","article-title":"Weight as a correlate of clinical response to psychotropic drugs","volume":"11","author":"Singh","year":"1970","journal-title":"Psychosomatics"},{"key":"10.1016\/j.ajp.2013.11.017_bib0270","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.b.20132","article-title":"Evidence for linkage between regulatory enzymes in glycolysis and schizophrenia in a multiplex sample","volume":"127B","author":"Stone","year":"2004","journal-title":"Am. J. Med. Genet. B: Neuropsychiatr. Genet."},{"key":"10.1016\/j.ajp.2013.11.017_bib0275","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbrc.2008.01.063","article-title":"Leptin as a neuroprotective agent","volume":"368","author":"Tang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ajp.2013.11.017_bib0280","first-page":"157","article-title":"Clozapine and weight gain","volume":"55 (Suppl. B)","author":"Umbricht","year":"1994","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0285","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/0253-7176.96172","article-title":"The \u2018Holy Grail\u2019 and \u2018Poisoned Chalice\u2019 Effects of Antipsychotics on Oxidative Stress in Schizophrenia: Can \u2018Hormesis\u2019 Explain this Paradox?","volume":"34","author":"Venkatasubramanian","year":"2012","journal-title":"Indian J. Psychological Med."},{"key":"10.1016\/j.ajp.2013.11.017_bib0290","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1176\/appi.ajp.2007.07020233","article-title":"Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia","volume":"164","author":"Venkatasubramanian","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0295","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/WNF.0b013e3181fa2a6f","article-title":"A longitudinal study on the impact of antipsychotic treatment on serum leptin in schizophrenia","volume":"33","author":"Venkatasubramanian","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ajp.2013.11.017_bib0300","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archpsyc.58.1.48","article-title":"Association of schizophrenia with low maternal body mass index, small size at birth, and thinness during childhood","volume":"58","author":"Wahlbeck","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2013.11.017_bib0305","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/npp.2008.214","article-title":"Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcers","volume":"34","author":"Waltz","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl. 18","key":"10.1016\/j.ajp.2013.11.017_bib0310","first-page":"13","article-title":"Schizophrenia and obesity: impact of antipsychotic medications","volume":"65","author":"Wirshing","year":"2004","journal-title":"J. Clin. Psychiatry"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201813003717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201813003717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:24:55Z","timestamp":1761755095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201813003717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":62,"alternative-id":["S1876201813003717"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2013.11.017","relation":{},"ISSN":["1876-2018"],"issn-type":[{"type":"print","value":"1876-2018"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between antipsychotic-induced metabolic side-effects and clinical improvement: A review on the Evidence for \u201cmetabolic threshold\u201d","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2013.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}